Sunday, May 22, 2016

Hebei Province Reports Rare H7N9 Case


Although China normally releases H7N9 information in monthly batches
(see China Reports 11 H7N9 Cases (7 Fatalities) In April) we occasionally see local reports on individual cases issued by local governments or carried by official state media.

Today, China's National Emergency Radio Network has a report on a recent H7N9 case in Hebei Province, who became symptomatic on May 10th.  

What makes this case a bit more interesting that most is that this is only the 2nd H7N9 case reported out of Hebei province in the four years since the virus emerged.

The last one was in July of 2013.  The following list is from Hong Kong CHP's latest Avian flu report

In the short history of H7N9 in China, case reports normally dropp off dramatically in May, and remain rare throughout the summer. The virus, however, continues to evolve, and so we keep close tabs year round looking for any signs that its behavior is changing.

Hengshui City, Hebei Province Diagnose H7N9 infection 

2016-05-22 12:21 Source: National Emergency Radio Network

Emergency Hebei May 22 news (reporter Wang up) According to Wei, Hebei Province Planning Commission website news, Hengshui City confirmed case of human infection of H7N9 virus. 
Zhao patients, male, 57 years old, Xinji City, farmers, headache fever symptoms on May 10, five days in the local treatment did not improve, on the 16th to a hospital Hengshui City hospital. 18, found that patients with positive screening samples of H7N9 in samples of sentinel hospitals in the routine monitoring of censorship, the prevention and control center in Hebei Province Disease Control Center and China Disease Prevention and detection of positive review, based on epidemiological history, clinical manifestations and laboratory chamber test results, diagnosis of human infection of H7N9 virus confirmed cases. 
The patient serious condition, are actively treatment. The patient has been in close contact with the 39 implementation of medical observation and found no abnormal clinical manifestations.